SCHEMBL22249658

SCHEMBL22249658

c1ccc(-c2cccc(-c3cc(-c4ccc(-c5ccncc5)cc4)nc(-c4ccc5c(c4)sc4cc6c7ccccc7c7ccccc7c6cc45)n3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.40
ALDH1A1 P00352 5/20 0.40
MAPT P10636 5/20 0.40
MEN1 O00255 5/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
LMNA P02545 3/20 0.40
DHODH Q02127 1/20 0.39
IMPDH2 P12268 1/20 0.38
GLA P06280 1/20 0.38
ROCK2 O75116 1/20 0.36
MAP4K4 O95819 1/20 0.36
PRKCG P05129 1/20 0.36
LYN P07948 1/20 0.36
PRKACA P17612 1/20 0.36
RPS6KB1 P23443 1/20 0.36
AKT1 P31749 1/20 0.36
FLT3 P36888 1/20 0.36
CSNK1D P48730 1/20 0.36
CLK2 P49760 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22249719 1.00 KMT2A (0.40) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL22250048 0.92 MAPT (0.38) ALDH1A1MAPTKDM4EHPGDLMNA
SCHEMBL22249659 0.88 MEN1 (0.46) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL19166687 0.87 KMT2A (0.43) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL22249736 0.87 MEN1 (0.44) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL14644646 0.87 KDM4E (0.38) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL19167103 0.87 MAPT (0.49) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL19168397 0.87 MAPT (0.49) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL19165259 0.86 DHODH (0.42) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL20977530 0.85 MEN1 (0.48) KMT2AALDH1A1MAPTMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 KMT2A 3007/4885ALDH1A1 63/4885MAPT 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.